Clearside Biomedical, Inc. - Common Stock (CLSD)
$0.92
0.04 (4.55%)
CLSD Stock Quote Delayed 30 Minutes
CLSD Stock Earnings: Clearside Biomedical Beats EPS, Misses Revenue for Q2 2024
CLSD stock results show that Clearside Biomedical beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
56.73M
PE Ratio
-2.04
EPS
-0.45
Volume (Avg. Vol.)
187,918
Day's Range
$0.86 - $0.92
52-Week Range
$0.80 - $2.12
Dividend & Yield
N/A (N/A)
